Role of Fra-2 in breast cancer: Influence on tumor cell invasion and motility

Breast Cancer Research and Treatment

Volumn 107, Issue 3, 2008, Pages 337-347

  Milde Langosch, Karin ^a   Janke, Stanislava ^a   Wagner, Ines ^a   Schröder, Christine ^a   Streichert, Thomas ^a   Bamberger, Ana Maria ^a   Jänicke, Fritz ^a   Löning, Thomas ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Albertinen Akademie Hamburg   (Germany)

Author keywords

Breast cancer; FOSL2; Fra 2; Invasion; Motility

Indexed keywords

COMPLEMENTARY DNA; CONNEXIN 43; INTERLEUKIN 24; MESSENGER RNA; PROTEIN MAGE; PROTEIN S 100; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR FRA 2; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DNA MICROARRAY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FOS-RELATED ANTIGEN-2; HUMANS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER;

EID: 38649108835     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9559-y     Document Type: Article

References (42)

1. Karin M, Liu Z-G, Zandi E (1997) AP-1 function and regulation. CurrOpinCell Biol 9:240-246
2. Tulchinsky E (2000) Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol 15:921-928
3. Milde-Langosch K (2005) The role of the Fos family of transcription factors in tumorigenesis. Eur J Cancer 41:2449-2461
4. Nishina H, Sato H, Suzuki T et al (1990) Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 87:3691-3623
5. Matsui M, Tokuhara M, Konuma Y et al (1990) Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5:249-255
6. Gruda MC, Kovary K, Metz R et al (1994) Regulation of fra-1 and fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9:2537-2547
7. Wisdom R, Verma IM (1993) Transformation by fos proteins requires a C-terminal transactivation domain. Mol Cell Biol 13:7429-7438
8. Bamberger A-M, Methner C, Lisboa BW et al (1999) Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive phenotype. Int J Cancer 84:553-558
9. Kustikova O, Kramerov D, Grigorian M et al (1998) Fra-1 induces morphological transformation and increases in vitro invasiveness and mobility of epithelioid adenocarcinoma cells. Mol Cell Biol 18:7095-7105
10. Andersen H, Mahmood S, Tkach V et al (2002) The ability of Fos family members to produce phenotypic changes in epitheloid cells is not directly linked to their transactivation potentials. Oncogene 21:4843-4848
11. Milde-Langosch K, Röder H, Andritzky B et al (2004) The role of the transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat 86:139-152
12. Milde-Langosch K, Bamberger A-M, Goemann C et al (2001) Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J Cancer Res Clin Oncol 127:537-544
13. Nandy A, Jenatschke S, Hartung B et al (2003) Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (PGDH) gene. Endocrinology 31:105-121
14. Vial E, Sahai E, Marshall CJ (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer cell 4:67-79
15. Rajagopalan D (2003) A comparison of statistical methods for analysis of high density oligonucleotide array data. Bioinformatics 19:1469-1476
16. Belguise K, Kersual N, Galtier F et al (2005) Fra-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24:1434-1444
17. Tkach V, Tulchinsky E, Lukanidin E et al (2003) Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene 22:5045-5054
18. Acquaviva C, Ferrara P, Bossis G et al (2001) Degradation of cellular and viral Fos proteins. Biochimie 83:357-362
19. Sonobe MH, Yoshida T, Murakami M et al (1995) Fra-2 promoter can respond to serum-stimulation through AP-1 complexes. Oncogene 10:689-696
20. Otte M, Zafrakas M, Riethdorf L et al (2001) MAGE-A gene expression pattern in primary breast cancer. Cancer Res 61:6682-6687
21. Taback B, Chan AD, Kuo CT et al (2001) Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay:correlations with clinical stage of disease. Cancer Res 61:8845-8850
22. King JA, Ofori-Acquah SF, Stevens T et al (2004) Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6:R478-R487
23. Rabeneau KE, O'Toole JM, Bassi R et al (2004) DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma:effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene 23:5056-5067
24. Laird DW, Fistouris P, Batist G et al (1999) Deficiency of connexin 43 gap junctions is an independent marker for breast tumors. Cancer Res 59:4104-4110
25. Qin H, Shao Q, Curtis H et al (2002) Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 277:29132-29138
26. Shao Q, Wang H, McLachlan E et al (2005) Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 65:2705-2711
27. Rakha EA, Boyce RW, Abd El-Rehim D et al (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18:1295-1304
28. De Bruin A, Muller E, Wurm S et al (1999) Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Adhes Commun 7:13-28
29. Tselepis C, Chidgey M, North A et al (1998) Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA 95:8064-8069
30. Wolverton T, Lalande M (2001) Identification and characterization of three members of a novel subclass of protocadherins. Genomics 76:66-72
31. Schmidt A, Jäger S (2005) Plakophilins - hard work in the desmosome, recreation in the nucleus? Eur J Cell Biol 84:189-204
32. Papagerakis S, Shabana AH, Depondt J et al (2003) Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Hum Pathol 34:565-572
33. Arumugam T, Simeone DM, Van Golen K et al (2005) S100P promotes pancreatic cancer growth, survival and invasion. Clin Cancer Res 11:5356-5364
34. Carlsson H, Petersson S, Enerback C (2005) Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int J Oncol 27:1473-1481
35. Brummer O, Athar S, Riethdorf L et al (1999) Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch 435:566-573
36. Remacle A, McCarthy K, Noel A et al (2000) High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer 89:118-121
37. Peters MG, Farias E, Colombo L et al (2003) Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res Treat 80:221-232
38. Porter S, Scott SD, Sassoon EM et al (2004) Dysregulated expression of adamalysin-thrombospondin gens in human breast carcinoma. Clin Cancer Res 10:2429-2440
39. Umetani N, Mori T, Koyanagi K et al (2005) Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene 24:4721-4727
40. Tsuchiya T, Okaji Y, Tsuno NH et al (2005) Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci 96:784-790
41. Inoue A, Omoto Y, Yamaguchi Y et al (2004) Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. J Mol Endocrinol 32:649-661
42. Bahassi EM, Karyala S, Tolinson CR et al (2004) Critical regulation of genes for tumor cell migration by AP-1. Clin Exp Met 21:293-304